SenoRx, Inc. Lowers IPO Price Range to $9-$10 per Share

March 29, 2007 |

1 min read

WASHINGTON, March 28 (Reuters) - Medical device maker SenoRx Inc. on Wednesday lowered its planned initial public offering to between $9 and $10 per share from a previous estimate of $11 to $13 each.

>>> Discuss This Story

IPO

MORE ON THIS TOPIC

Business people shaking hand in China.

GLP-1

Pfizer Builds Global GLP-1 Strategy With up to $495M Sciwind Deal

February 24, 2026

·

2 min read

·

Tristan Manalac

Contemporary art collage. Purple hand holding fan of dollar bills against bright yellow background. stock photo

Collaboration

Astellas Bets up to $1.7B for Vir’s ‘Robust Competitor’ in Prostate Cancer

February 24, 2026

·

2 min read

·

Tristan Manalac

IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch

IPO tracker

Generate’s IPO Could Reach $425M, Largest Raise Yet

February 24, 2026

·

5 min read

·

Tristan Manalac

Hand collage holding dollar paper money isolated on yellow background. Using cash to buy concept. Halftone effect in pop art style illustration.

Mergers & acquisitions

Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition

February 23, 2026

·

2 min read

·

Tristan Manalac